Skip to main content

Advertisement

SpringerLink
Log in

Prognostic Significance of Cyclin D1 and E-cadherin Expression in Laryngeal Squamous Cell Carcinoma

  • Research
  • Published:
Pathology & Oncology Research

Abstract

Cyclin D1 and E-cadherin are important factors in the progression and metastasis of cancers. Their role in laryngeal carcinoma has been studied with conflicting results. To define the frequency of cyclin D1 and E-cadherin expression and its correlation with both the clinicopathological characteristics and prognosis of patients with laryngeal squamous cell carcinoma (LSCC). Tumor tissue samples from 75 patients with laryngeal squamous cell carcinoma were examined for cyclin D1 and E-cadherin expression by immunohistochemistry. The relationship between the expression of both molecules and the age and sex of the patient, tumor site, tumor differentiation, lymph node metastasis, tumor invasiveness, TNM stages, tumor recurrence and overall survival was analyzed. Cyclin D1 was found to be a significant independent prognostic factor of lymph node metastasis (p = 0.000). The multivariate analysis revealed that cyclin D1 and E-cadherin expression wasn’t an independent prognostic factor of local recurrence free survival (LRFS) in patients with LSCC (P = 0.56 and 0.28) respectively. However, the univariate analysis revealed a significant association between them and LRFS (p = 0.003 and 0.000) respectively. Also, the group of high cyclin D1 /low E-cadherin expression had the poorest prognosis, so they might serve as potential predictors of the prognosis of the patients with LSCC. E-cadherin was found to affect the overall survival (OAS) significantly by the univariate analysis (p = 0.01). However, by the multivariate analysis the TNM stage was the only independent prognostic factor of OAS (p < 0.05). Cyclin D1 can be used as an independent prognostic marker of lymph node metastasis in patients with LSCC and can help to identify those patients with clinically negative lymph nodes but with considerable risk for occult metastasis. Detection of cyclin D1 and E-cadherin status in LSCC may contribute to the identification of patients with high risk factors of local recurrence. However, they don’t appear to be better prognostic predictors than other established markers in LSCC.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Luke CG, Yeoh E, Roder DM (2008) Exploring trends in laryngeal cancer incidence, mortality and survival: implications for research and cancer control. Asian Pac J Cancer Prev 9(3):397–402

    PubMed  Google Scholar 

  2. Freedman LS, Edwards BK, Ries LAG et al (2006) Cancer incidence in four member countries (Cyprus, Egypt, Israel, and Jordan) of the Middle East Cancer Consortium (MECC) compared with US SEER. National Cancer Institute. NIH Pub. No. 06–5873. Bethesda, MD. Chapter title; Overview and Summary Data; (1): pp 1–27. Edited by Freedman LS, Edwards BK, Ries LAG, et al

  3. Torrente MC, Rodrigo JP, Haigentz M et al (2011) Human papillomavirus infections in laryngeal cancer. Head Neck 33(4):581–586

    Article  PubMed  Google Scholar 

  4. Krecicki T, Smigiel R, Fraczek M et al (2004) Studies of the cell cycle regulatory proteins, P16, cyclinD1and retinoblastoma protein in laryngeal carcinoma tissue. J Laryngol Otol 118(9):676–680

    Article  PubMed  Google Scholar 

  5. Cristóbal E, Arribas B, Tardio J et al (2000) Analysis of the cyclin D1/p16/pRb pathway in parathyroid adenomas. Endocr Pathol 11(3):259–266

    Article  PubMed  Google Scholar 

  6. vanDiest PJ, Michalides RJAM, Jannink I et al (1997) Cyclin D1 expression in invasive breast cancer: correlations and prognostic value. Am J Pathol 150(2):705–711

    CAS  Google Scholar 

  7. Ishikawa T, Furihata M, Ohtsuki Y et al (1998) Cyclin D1 overexpression related to retinoblastoma protein expression as a prognostic marker in human oesophageal squamous cell carcinoma. Br J Cancer 77(1):92–97

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  8. Wangefjord S, Manjer J, Gaber A et al (2011) Cyclin D1 expression in colorectal cancer is a favourable prognostic factor in men but not in women in a prospective, population-based cohort study. Biol Sex Differ 2:10

    Article  PubMed Central  PubMed  Google Scholar 

  9. Ito Y, Matsuura N, Sakon M et al (1999) Expression and prognostic roles of the G1-S modulators in hepatocellular carcinoma: p27 independently predicts the recurrence. Hepatology 30(1):90–99

    Article  CAS  PubMed  Google Scholar 

  10. Fracchiolla NS, Pruneri G, Pignataro L et al (1997) Molecular and immunohistochemical analysis of the bcl-1/cyclin D1 gene in laryngeal squamous cell carcinomas: correlation of protein expression with lymph node metastases and advanced clinical stage. Cancer 79(6):1114–1121

    Article  CAS  PubMed  Google Scholar 

  11. Do NY, Park SY, Lim SC (2004) The role of E-cadherin/B2-catenin complex and cyclin D1 in head and neck squamous cell carcinoma. Cancer Res Treat 36(1):72–78

    Article  PubMed Central  PubMed  Google Scholar 

  12. Berx G, Staes K, van Hengel J et al (1995) Cloning and characterization of the human invasion suppressor gene E-cadherin (CDH1). Genomics 26(2):281–289

    Article  CAS  PubMed  Google Scholar 

  13. Kashibuchi K, Tomita K, Schalken JA et al (2006) The prognostic value of E-cadherin, alpha-, beta-, and gamma-catenin in urothelial cancer of the upper urinary tract. Eur Urol 49(5):839–845

    Article  CAS  PubMed  Google Scholar 

  14. Loddo M, Kingsbury SR, Rashid M et al (2009) Cell-cycle-phase progression analysis identifies unique phenotypes of major prognostic and predictive significance in breast cancer. Br J Cancer 100(6):959–970

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  15. Barnes L, Eveson JW, Reichart PA et al (2005) World Health Organization classification of tumors: pathology and genetics of tumors of the head and neck. Lyon: IARC. Squamous cell carcinoma in; Hypopharynx, larynx and trachea; (3): p p121. Edited by Cardesa A, Gale N, Nadal A et al

  16. Edge SB, Byrd DR, Compton CC et al (2010) Larynx. In: AJCC cancer staging manual, 7th edn. Springer, New York, pp 57–62

    Google Scholar 

  17. Larizadeh MH, Damghani MA, Tabrizchi H et al (2009) Expression of E-cadherin in squamous cell carcinoma of the larynx and its correlation with clinicopathological features. J Med Sci 9(1):41–45

    Google Scholar 

  18. Leon X, Lopez M, Garcia J et al (2008) Recurrent laryngeal squamous cell carcinoma: rTNM versus composite laryngeal recurrence staging system. Proposal for a modification of the CLRSS to improve patient classification. Head Neck 30(7):939–945

    Article  PubMed  Google Scholar 

  19. Awada A, Lalami Y (2005) Molecular markers, molecular-targeted therapies and taxanes: how to integrate the progress into clinical research and practice for the management of head and neck cancers. Curr Opin Oncol 17(3):209–211

    Article  PubMed  Google Scholar 

  20. Zhang Y, Xu Z, Jun-Xi Wang J et al (2012) G1/S-specific cyclin-D1 might be a prognostic biomarker for patients with laryngeal squamous cell carcinoma. Asian Pac J Cancer Prev 13(5):2133–2137

    Article  PubMed  Google Scholar 

  21. Pignataro L, Sambataro G, Pagani D et al (2005) Clinico-prognostic value of D-type cyclins and p27 in laryngeal cancer patients: a review. Acta Otorhinolaryngol Ital 25(2):75–85

    CAS  PubMed Central  PubMed  Google Scholar 

  22. Vielba R, Eng JBC, Ispizua A et al (2003) Cyclin D1 as prognostic factors in squamous cell carcinoma of the larynx. Laryngoscope 113(1):167–172

    Article  CAS  PubMed  Google Scholar 

  23. Galera-Ruiz H, Ríos-Moreno MJ, González-Cámpora R (2012) The cadherin-catenin complex in laryngeal squamous cell carcinoma. Eur Arch Otorhinolaryngol 269(4):1183–1188

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  24. Li JJ, Zhang GH, Yang XM et al (2012) Reduced E-cadherin expression is associated with lymph node metastases in laryngeal squamous cell carcinoma. Auris Nasus Larynx 39(2):186–192

    Article  PubMed  Google Scholar 

  25. Paksoy M, Hardal U, Caglar C (2011) Expression of cathepsin D and E-cadherin in primary laryngeal cancers correlation with neck lymph node involvement. J Cancer Res Clin Oncol 137(9):1371–1377

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  26. Rodrigo JP, Domínguez F, Alvarez C et al (2002) Expression of E-cadherin in squamous cell carcinomas of the supraglottic larynx with correlations to clinicopathological features. Eur J Cancer 38(8):1059–1064

    Article  CAS  PubMed  Google Scholar 

  27. Rodrigo JP, Dominguez F, Suárez V et al (2007) Focal adhesion kinase and E-cadherin as markers for nodal metastasis in laryngeal cancer. Arch Otolaryngol 133(2):145–150

    Article  Google Scholar 

  28. Michalides RJAM, van Veelen NMJ, Kristel PMP et al (1997) Overexpression of cyclin D1 indicates a poor prognosis in squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg 123(5):497–502

    Article  CAS  PubMed  Google Scholar 

  29. Pignataro L, Capaccio P, Pruneri G et al (1996) P53 and cyclin D1 protein expression in glottic laryngeal squamous cell carcinomas involving the anterior commissure (pT1bN0M0). Int J Oncol 3(9):553–557

    Google Scholar 

  30. Snow GB, Patel P, Leemans CR et al (1992) Management of cervical lymph nodes in patients with head and neck cancer. Eur Arch Otorhinolaryngol 249:187–194

    Article  CAS  PubMed  Google Scholar 

  31. Zou J, Yang H, Chen F et al (2010) Prognostic significance of fascin-1 and E-cadherin expression in laryngeal squamous cell carcinoma. Eur J Cancer Prev 19(1):11–17

    Article  CAS  PubMed  Google Scholar 

  32. Pruneri G, Pignataro L, Valentini S et al (2005) Cyclin D3 immunoreactivity is an independent predictor of survival in laryngeal squamous cell carcinoma. Clin Cancer Res 11(1):242–248

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Pathology Department, Faculty of Medicine, Mansoura University, Mansoura, Egypt

    Rehab Allah Ahmed & Abd El-Aty Shawky

  2. Department of Clinical Oncology and Nuclear Medicine, Faculty of Medicine, Mansoura University, Mansoura, Egypt

    Rasha Hamdy Hamed

Authors
  1. Rehab Allah Ahmed
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Abd El-Aty Shawky
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Rasha Hamdy Hamed
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Rasha Hamdy Hamed.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ahmed, R.A., Shawky, A.EA. & Hamed, R.H. Prognostic Significance of Cyclin D1 and E-cadherin Expression in Laryngeal Squamous Cell Carcinoma. Pathol. Oncol. Res. 20, 625–633 (2014). https://doi.org/10.1007/s12253-014-9741-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12253-014-9741-6

Keywords

Search

Navigation